Showing results 4 to 9 of 9
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models Journal:Cancer Letters | 2014 | 83 | ||
2011 | 201 | |||
2011 | 182 | |||
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells Journal:Investigational New Drugs | 2010 | 152 | ||
Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs | 2013 | 60 | ||
The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines Journal:Investigational New Drugs | 2010 | 292 |